Glucocorticoid and cyclic AMP increase tyrosine hydroxylase (TH) activity and mRNA levels in pheochromocytoma cultures. The transcriptional activity of the TH gene, as measured by nuclear run-on assay, is also increased when cultures are treated with the synthetic glucocorticoid dexamethasone or agents that increase intracellular cyclic AMP, such as forskolin and 8-BrcAMP. Both inducers effect transcriptional changes within 10 min after treatment and are maximal after 30 min for forskolin and after 60 min for dexamethasone. The 5' flanking sequences of the TH gene were fused to the bacterial gene chloramphenicol acetyltransferase (CAT), and the hybrid gene was transfected into pheochromocytoma cultures and GH4 pituitary cells. In both cell lines, a region of the TH gene containing bases -272 to +27 conferred induction of CAT by cyclic AMP, but not by glucocorticoid. The same results were found when a region of the TH gene containing -773 to +27 was used. Thus, the sequences required for induction of TH by cyclic AMP are contained within 272 bases of 5' flanking sequence, but sequences sufficient for glucocorticoid regulation are not contained within 773 bases.
The rate of biosynthesis of specific neurotransmitters can be modulated by a variety of environmental, neuronal, and hormonal stimuli. In catecholamine biosynthesis, the rate of flow through the pathway is largely dependent on the activity of the initial enzyme, tyrosine hydroxylase (TH), which is expressed in the adrenal medulla, sympathetic ganglia, and certain defined nuclei of the brain. Activity of tyrosine hydroxylase can be modulated both by changes in the synthetic rate of new tyrosine hydroxylase polypeptide and by posttranslational modification of preexisting enzyme molecules.
The synthesis of TH is influenced by a variety of factors; in vivo, TH is induced in response to environmental stimuli, such as stress (1), and this induction can be mimicked pharmacologically by treatment of animals with agents that deplete cellular catecholamine stores, such as reserpine (2) . In cultures of adrenal chromaffin or pheochromocytoma cells, tyrosine hydroxylase activity is induced by a number of effectors, including glucocorticoid (3, 4) , cyclic AMP (5, 6) , epidermal growth factor (7) , and nerve growth factor (6, 8, 9) .
Whether these effectors act through similar mechanisms and whether changes are modulated transcriptionally or posttranscriptionally is not known. Using a cloned cDNA probe for TH, we have previously shown increases in the mRNA for tyrosine hydroxylase following treatment of clonal rat pheochromocytoma cells from an adrenal medullary tumor with analogs of cyclic AMP and glucocorticoid (10) . The TH RNA is also increased in adrenal glands and superior cervical ganglia in vivo when animals are subjected to cold stress or reserpine treatment (11) (12) (13) (14) . In this communication, we have extended those studies by demonstrating that both glucocorticoid and cyclic AMP stimulate the transcriptional activity of the TH gene. In addition, we report that the 5 (18) to nick-translated pTH.4, a cDNA for rat tyrosine hydroxylase (10) . The transcriptional initiation site of TH RNA was mapped by S1 nuclease protection and reverse transcription methods (16) . Fragments were subcloned into M13 and the DNA sequence was determined by dideoxy-chain termination (19) . A fragment of0.8 kb from an HindIII complete Alu I partial digest of the TH gene, which contained the promoter region, was gel-purified and cloned into the HindIll and Sma I sites of pUC CAT (Fig. 2 A and B) . The pUC CAT vector contains the CAT gene segment from pSV2 CAT (20) fused to pUC13 (21) , such that the polylinker region of pUC13 directly precedes transcriptional initiation of the CAT gene. pUC CAT was given to us by Richard Morimoto (Northwestern University). The 0.8-kb TH fragment contains 773 bases of 5' flanking sequence, the transcription initiation site, and 27 bases of transcribed nontranslated sequences. This construct is designated 5'TH CAT (+27/-773). A second construct, 5'TH CAT (+27/-272), was generated by digestion of the former plasmid with Sst I and HindIII, followed by a fill-in reaction with the Klenow fragment of DNA polymerase I (22) and religation. The junction of the TH-CAT hybrid gene was confirmed by sequence analysis (23) .
All enzymes used in DNA cloning were purchased from Bethesda Research Laboratories.
DNA Transfections. PC7e cells were plated at 5 x 105 cells per 100-mm dish 2 days prior to transfection. CaPO4/DNA precipitates (24) containing [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ,ug of plasmid DNA that had been purified through CsCl were added to cultures in 0.3-0.5 ml. In experiments in which multiple cultures were transfected with the same plasmid, several individually prepared CaPO4/DNA precipitates were pooled and then added to cultures. Cultures were incubated with precipitate for 4 hr at 37°C, and then medium was removed and cultures were treated with 5 ml of 15% (vol/vol) glycerol. Cultures were incubated for 4 min at room temperature, washed twice with phosphate-buffered saline, and reincubated at 37°C overnight in serum-containing medium. Inducers were added the following day.
GH4 cultures were inoculated at 106 cells per 100-mm plate 2 days prior to the beginning of the experiment and were transfected by the DEAE-dextran method as described by Camper et al. (25) .
Assay of CAT. Transfected cells were pelleted, suspended in 100 .ul of 0.25 M Tris HCl (pH 7.6), and extracted by three freeze-thaw cycles. Cytosolic protein was assayed as described by Gorman et al. (20) . Results are expressed as the percentage of radiolabel present on the plate that was acetylated. Background activity was determined from extracts that had been transfected with the promoterless pUC CAT.
RESULTS
Analysis of Nuclear Transcription from the TH Gene. In previous studies, we had demonstrated that TH mRNA levels were increased by treatment of pheochromocytoma cultures with the synthetic glucocorticoid, dexamethasone, or with agents that increase intracellular cyclic AMP (10) . In a number of different experiments using the clonal PC7e cell line, dexamethasone increased TH RNA 3.5-to 6-fold, while cyclic AMP-mediated increases in TH RNA were 2-to 3.5-fold over basal levels. These changes in message level could be due to stimulation oftranscription of the TH gene or to enhanced stability of preexisting TH mRNA molecules. The relative transcriptional activity of the TH gene was evaluated by performing a nuclear "run-on" assay in nuclei ofpheochromocytoma cultures treated with either dexamethasone or forskolin, an activator of adenylate cyclase. In the nuclear run-on assays, the transcriptional activity from the TH gene relative to total nuclear transcriptional activity is measured by elongating nascent RNA chains in isolated nuclei in the presence of ribonucleoside [32P] triphosphate for 30 min. Treatment of PC7e cultures with either forskolin or dexamethasone produced a marked stimulation in the transcriptional activity from the TH gene (Fig. 1) (32, 33) .
5'TH CAT (+27/-773) was introduced into GH4 cultures by DEAE-dextran transfection. Treatment of cultures with forskolin or 8-BrcAMP resulted in a 2-and 2.2-fold increase of CAT activity, respectively, while treatment of cultures with dexamethasone produced no induction (Fig. 4A) . pSV2 CAT is not expressed in GH4 cells (25) , but RSV CAT is expressed at high levels in these cells (25) . The expression of CAT activity from RSV CAT was not altered by treatment with inducers (Fig. 4B) .
The change in CAT activity was monitored over a 2-day period following transfection to determine the magnitude of induction over time after inducer treatment. In this experiment, forskolin was added to cultures directly after introduction of foreign DNA, while in previous experiments cells were allowed to recover from the transfection procedure for 24 hr prior to addition of inducer. Initial detection of CAT activity was observed 18 hr after transfection and rose gradually thereafter (Fig. 4C) . In cultures treated with forskolin, CAT activity was increased over basal levels by 24 provide evidence that both effectors rapidly stimulate transcription from the TH gene as assayed by run-on transcription from isolated nuclei. After 24 hr of treatment, the magnitude of transcriptional stimulation with inducers was reproducibly greater than the increase of TH RNA levels, suggesting that additional posttranscriptional controls may also contribute to the levels of stable TH RNA. The initial change in TH transcription is observed within 10 min after addition of inducer to cultured cells. In contrast, changes in TH RNA levels are first observable 3-4 hr after inducer treatment (10, 34) , while increases in TH enzyme activity are usually not observed until [8] [9] [10] [11] [12] [13] [14] [15] [16] hr after inducer treatment (10, 35) . The delayed appearance of stable RNA and protein probably reflects the fact that the time required to reach new steady-state values is dependent on the degradation rate (not synthetic rate) of TH RNA and protein. The apparent half-life of TH protein is -30 hr (35) , and, if the half-life of TH RNA were typical of other cellular RNAs (between 5 and 20 hr), the lag between transcriptional activation and the appearance of stable macromolecules would be expected. In this regard, several other mammalian genes that are transcriptionally regulated by glucocorticoids (36) (37) (38) (39) and cyclic AMP (32, (40) (41) (42) (43) have similar delays between rapid transcriptional events and the resulting changes in stable RNA levels.
Cyclic AMP has been recently demonstrated to increase specific mRNA levels for a number of neuropeptide precursor genes (44) (45) (46) . It is of interest to determine whether there is a generalized program by which cyclic AMP can increase production of specific neurotransmitter, and whether this mechanism extends to other genes under transcriptional control by cyclic AMP. A fragment of the 5' flanking region of the TH gene, including bases -272 to +27, is able to confer responsiveness to cyclic AMP onto a heterologous gene. It is not clear at this juncture whether this region comprises the sole cyclic AMP responsive element in the TH gene, nor is it known whether this fragment is composed of multiple elements. It has recently been noted that a number of genes regulated by cyclic AMP contain a homologous sequence, the core of which is TGACGTCA (27) (28) (29) , and which is present at -44 to -37 in the TH gene (Fig. 2C ). This core sequence alone will not confer responsiveness to cyclic AMP onto a heterologous gene, but in the somatostatin and proenkephalin genes a region of 30 bases, including and surrounding this core, can confer CAT gene induction by cyclic AMP (27, 29) . In contrast to the ability of the 5' flanking region of the TH gene to confer induction by cyclic AMP onto the CAT gene, treatment with glucocorticoid does not generate increases in CAT actiyity that could account for the 3.5-to 6-fold increase in TH RNA levels. This was somewhat surprising, as sequences -454 to -443 of the TH gene bear homology in 10 of 11 consecutive bases to sequences in the human metallothionein gene that comprise a portion of the glucocorticoid regulatory element of that gene (30) . These results suggest that comparison of consensus sequence homologies between hormone-responsive genes does not necessarily identify an active regulatory element. 40 of duplicate samples, which deviate from the mean Hours by <10% (A), <25% (B), and <20% (C).
gene, perhaps in an intron, as has been demonstrated for the growth hormone gene (47, 48) . Alternatively, there may be multiple elements on the TH gene that act cooperatively to invoke transcriptional stimulation by glucocorticoid. The decrease in CAT activity observed with the -773 construct and the small increase with the -272 construct suggest that there may be both inhibitory and stimulatory sequences involved in the TH glucocorticoid response. Primer extension and riboprobe transcription mapping analyses demonstrated that the 5' end for the TH transcript from control and dexamethasone-treated cultures is the same (16), suggesting that both transcripts are initiated from the same promoter. Thus, it is unlikely that the lack of glucocorticoid responsiveness from the 5' flanking sequences is due to a missing glucocorticoid-specific promoter.
The observation that the TH promoter was active in GH4 cells was somewhat unexpected, since for many tissuespecific genes, elements encoded on the DNA restrict the expression of those genes to the appropriate cell type. The possibility that these observations provide information concerning the mechanism of expression of the TH gene, such as the presence of upstream inhibitory elements, will be of interest for future investigation.
